Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IA Melphalan and Carboplatin with BBBD for CNS Embryonal or Germ Cell Tumors
NCT00983398Phase 2Unknown
- Sponsor
- OHSU Knight Cancer Institute
- Start
- Jul 2009
- Primary completion
- Dec 2021
- Countries
- 1
01
Overview
A Phase 2 trial of melphalan in Embryonal tumor of the central nervous system, germ cell tumor (GCT), medulloblastoma, Atypical teratoid rhabdoid tumor (ATRT), medulloepithelioma, sponsored by OHSU Knight Cancer Institute. Status: unknown.
02
Drugs
melphalan
03
Conditions
Embryonal tumor of the central nervous systemgerm cell tumor (GCT)medulloblastomaAtypical teratoid rhabdoid tumor (ATRT)medulloepithelioma
Beyond the preview
Go deeper on NCT00983398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00983398.